Document is current
Any future updates will be listed below
-
Authors
Louet, Estelle R. https://orcid.org/0000-0001-6983-1820
Glavan, Martina
Orset, Cyrille
Parcq, Jerome
Hanley, Daniel F.
Vivien, Denis https://orcid.org/0000-0002-7636-2185
-
Funding
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (813294)
Agence Nationale de la Recherche
- License Information
-
More Information
Article History
Received: 8 October 2021
Revised: 3 March 2022
Accepted: 4 March 2022
First Online: 21 March 2022
Declarations
:
: Op2Lysis has no financial interest in the research described in this paper. D. Vivien is co-author of the patent for Glunomab “NOVEL ANTIBODY USEFUL IN NEUROLOGICAL OR NEURODEGENERATIVE DISORDERS,” Publication number: 20180371082.
